RT Journal Article
SR Electronic
T1 Genetic and non-genetic components of family history of stroke and heart disease: a population-based study among adopted and non-adopted individuals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.28.23290649
DO 10.1101/2023.05.28.23290649
A1 Mayerhofer, Ernst
A1 Parodi, Livia
A1 Narasimhalu, Kaavya
A1 Harloff, Andreas
A1 Georgakis, Marios K
A1 Rosand, Jonathan
A1 Anderson, Christopher D
YR 2023
UL http://medrxiv.org/content/early/2023/06/03/2023.05.28.23290649.abstract
AB Background It is increasingly clear that genetic and non-genetic factors account for the association of family history with disease risk in offspring. We sought to distinguish the genetic and non-genetic contributions of family history of stroke and heart disease on incident events by examining adopted and non-adopted individuals.Methods We examined associations between family history of stroke and heart disease with incident stroke and myocardial infarction (MI) in 495,640 participants of the UK Biobank (mean age 56.5 years, 55% female) stratified by early childhood adoption status into adoptees (n=5,747) and non-adoptees (n=489,893). We estimated hazard ratios (HRs) per affected nuclear family member, and for polygenic risk scores (PRS) for stroke and MI in Cox models adjusted for baseline age and sex.Results 12,518 strokes and 23,923 MIs occurred over a 13-year follow-up. In non-adoptees, family history of stroke and heart disease were associated with increased stroke and MI risk, with the strongest association of family history of stroke for incident stroke (HR 1.16 [1.12, 1.19]) and family history of heart disease for incident MI (HR 1.48 [1.45, 1.50]). In adoptees, family history of stroke associated with incident stroke (HR 1.41 [1.06, 1.86]), but family history of heart disease did not associate with incident MI (p>0.5). PRS showed strong disease-specific associations in adoptees and non-adoptees. In non-adoptees, the stroke PRS mediated 6% risk between family history of stroke and incident stroke, and the MI PRS mediated 13% risk between family history of heart disease and MI.Conclusions Family history of stroke and heart disease increase risk for their respective conditions. Family history of stroke contains a substantial proportion of potentially modifiable non-genetic risk, indicating a need for further research to elucidate these elements for novel prevention strategies, whereas family history of heart disease represents predominantly genetic risk.Graphic abstract Competing Interest StatementCDA has received sponsored research support from Bayer AG and has consulted for ApoPharma unrelated to this work. JR reports compensation from National Football League and Takeda Development Center Americas for consultant services, unrelated to this work.Funding StatementCDA is supported by NIH R01NS103924, U01NS069673, American Heart Association 18SFRN34250007 and 21SFRN812095, and the Massachusetts General Hospital McCance Center for Brain Health for this work. MKG is supported from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) with a Walter-Benjamin Fellowship (GZ: GE 3461/1-1, ID: 466957018), within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy, ID 390857198), and with an Emmy Noether grant (GZ: GE 3461/2-1, ID 512461526), as well as grants from the Fritz-Thyssen Foundation (Ref. 10.22.2.024MN) and the Hertie Foundation (Hertie Network of Excellence in Clinical Neuroscience, ID P1230035). JR receives research grants from NIH and the American Heart Association-Bugher Foundation. AH is supported by the Berta-Ottenstein programm for Advanced Clinician Scientists, Medical Faculty, University of Freiburg, Germany.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UKB was approved by the North West Multi-centre Research Ethics Committee, and all participants provided informed consent. We accessed the data following approval of an application by the UKB Ethics and Governance Council (Application No. 36993).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesUKB participant data can be accessed by submitting an approved research proposal to UKB. The GWAS summary statistics used to create genetic scores are publicly accessible.